Recordati Rare Diseases, Inc. (RRD) is the North American affiliate of Recordati, an international pharmaceutical group focused on developing and commercializing treatments for rare diseases and common conditions. It provides orphan therapies to underserved rare disease communities, particularly in Canada and the US, with operations including clinical trials, regulatory affairs, and commercial activities. The parent company, headquartered in Milan, Italy, operates in around 150 countries with a portfolio spanning specialty care, primary care, and rare diseases.